BioSpace News Archive

ANANDA Scientific Inc today announced approval by the US Food and Drug Administration (FDA) of the IND application for a clinical trial evaluating Nantheia™ A1002N5S.

Elevation Oncology, Inc. today announced that Shawn M. Leland , PharmD, RPh, Founder and Chief Executive Officer of Elevation Oncology, will participate in a fireside chat at the JMP Securities Hematology and Oncology Summit on Tuesday, December 6, 2022 at 11:00 am ET.

SurgiBox Inc. today announced CE Marking for its Smart Control Module 001-SCM-0000 and its Battery Pack BP-04002M.

Wiley will release its second quarter 2023 results prior to market open on Wednesday, December 7, 2022.

Cerevance, a private, clinical-stage drug discovery and development company focused on central nervous system (CNS) diseases, today announced the presentation of preclinical data supporting the use of the company’s Nuclear Enriched Sort sequencing (NETSseq) technology platform to identify novel, druggable targets involved in the regulation of neuroinflammation in Alzheimer’s disease (AD).

Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism pioneering therapies for rare diseases, announced that the company is scheduled to present at the Bank of America 2022 Virtual Biotech SMID Cap Conference on Wednesday, December 7, 2022, at 11:25 a.m. ET.

Serenus.AI and HealthTrio are continuing an established partnership to launch an AI-based module to streamline and automate medical authorizations for knee replacements.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for Evkeeza® (evinacumab-dgnb) as an adjunct to other lipid-lowering therapies to treat children aged 5 to 11 years with homozygous familial hypercholesterolemia (HoFH).

Experic , a contract development and manufacturing organization (CDMO) and clinical supply services company serving the biopharmaceutical industry, today announced the closing of a $14 million series B capitalization led by Harro Höfliger Packaging Systems, Inc. and East Seattle Partners.

Altamira Therapeutics Ltd. (NASDAQ: CYTO), a company dedicated to developing therapeutics that address important unmet medical needs, today announced that its licensee and distribution partner Nuance Pharma has launched its Bentrio nasal spray in Hong Kong.